X

2019 ASCPT Board of Directors Appointments (Press Releases)

Author: [AUTHOR] Published on 1/25/2019 11:06:00 AM


ASCPT is pleased to announce that beginning in March 2018, David Mitchell, PhD will serve a 1-year term as President of the American Society for Clinical Pharmacology and Therapeutics (ASCPT). Click here for press release.

   

Susan Abdel-Rahman, PharmD, has been appointed President-Elect of ASCPT. Dr. Abdel-Rahman has been an active member of ASCPT for over 15 years, serving on the Board of Directors and the Scientific Program Committee, the Scientific Awards Task Force, the Education Committees and the Society's Mentoring Program. Click here for press release.

   
Jacques Turgeon, PhD has been appointed is the newest member of the ASCPT Board of Directors.  He will be serving a 3-year term as the Treasurer.  He will officially begin his appointment as treasurer in March 2019.  Click here for press release.
 
Also joining the Board of Directors as of March 2019 are:

Tamorah Lewis, MD, PhD is one of the newest members of the ASCPT Board of Directors.  Dr. Lewis will serve a 3-year term as an at-large director. Click here for press release.
   

Michelle Rudek, PhD, PharmD, is one of the newest members of the ASCPT Board of Directors. Dr. Rudek will serve a 3-year term as an at-large director. Click here for press release.

print
Sort by:
Photo Gallery
Recent News
  • Machine Learning to Improve Speed and Quality of Drug Development?
    May 20, 2025
  • CPT Call for Papers: Elevating the Global Impact of Clinical Pharmacology
    May 15, 2025
  • ASCPT Adviser: May 2025
    May 08, 2025
Contact Us